SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kabra Drugs informs about proceedings of EGM

26 Dec 2025 Evaluate

Pursuant to Regulation 30 read with Para A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Kabra Drugs has informed that it enclosed proceedings of the Extra-Ordinary General Meeting of the Company held on Friday, 26th December 2025 at 09:00 am at Ginger Hotel, Chhoti Khajrani, A B Road, Indore, Madhya Pradesh 452008.

The above information is a part of company’s filings submitted to BSE.

Kabra Drugs Share Price

26.05 -0.73 (-2.73%)
12-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1845.90
Dr. Reddys Lab 1270.10
Cipla 1292.00
Zydus Lifesciences 930.75
Lupin 2246.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×